Shanghai Junshi Biosciences Co., Ltd. (OTCMKTS:SHJBF – Get Rating) saw a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 969,400 shares, an increase of 28.5% from the May 15th total of 754,400 shares. Based on an average daily volume of 0 shares, the days-to-cover […]
Shanghai Junshi Biosciences Co., Ltd. (OTCMKTS:SHJBF – Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 969,400 shares, a growth of 28.5% from the May 15th total of 754,400 shares. Based on an average daily volume of 0 […]
– Toripalimab plus chemotherapy resulted in a 37% reduction in the risk of death, HR=0.63, versus chemotherapy alone, in nasopharyngeal carcinoma patients.
– Toripalimab plus chemotherapy resulted in a 37% reduction in the risk of death, HR=0.63, versus chemotherapy alone, in nasopharyngeal carcinoma patients – – No treatments are. | June 5, 2023